Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges.
Int J Mol Sci
; 16(12): 28614-34, 2015 Dec 02.
Article
em En
| MEDLINE
| ID: mdl-26633382
ABSTRACT
Embryonic stem cells (ESCs) are chiefly characterized by their ability to self-renew and to differentiate into any cell type derived from the three main germ layers. It was demonstrated that somatic cells could be reprogrammed to form induced pluripotent stem cells (iPSCs) via various strategies. Gene editing is a technique that can be used to make targeted changes in the genome, and the efficiency of this process has been significantly enhanced by recent advancements. The use of engineered endonucleases, such as homing endonucleases, zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs) and Cas9 of the CRISPR system, has significantly enhanced the efficiency of gene editing. The combination of somatic cell reprogramming with gene editing enables us to model human diseases in vitro, in a manner considered superior to animal disease models. In this review, we discuss the various strategies of reprogramming and gene targeting with an emphasis on the current advancements and challenges of using these techniques to model human diseases.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Engenharia Genética
/
Marcação de Genes
/
Reprogramação Celular
/
Células-Tronco Pluripotentes Induzidas
/
Modelos Biológicos
Idioma:
En
Ano de publicação:
2015
Tipo de documento:
Article